COAG
$34.17+6.48%
COAG — Hemab Therapeutics Holdings Inc. price, chart and key statistics
Technical analysis2
Overlay lines0
Addendum charts0
VolumeEE
25.030.035.040.045.050.002.0M4.0M$34.17—MayJunJulSepOct
2026-10-20
Price$34.17
MA20$31.75
MA50$40.32
Vol396.1K
Key stats#
Price data
- Price
- $34.17
- YTD price return
- —
- YTD total return
- —
- Next earnings
- Nov 10, 2026
- Market cap
- 1B
- Enterprise value
- 572.5M
- Shares outstanding
- 30.1M
- 52W low
- $23.00
- 52W high
- $55.42
- From 52W high
- -38.34%
- From 52W low
- +48.57%
- 52W range
- 34%
Volume
- Rel volume
- 0.72×
- 30D volume
- 551.3K
- 30D $ vol
- 20M
Fundamentals
- Current ratio
- 35.85
Valuation
- Fwd P/E
- -13.4×
- P/B (mrq)
- 2.3×
Performance · price return · as of 2026-10-20#
1D
+6.48%
5D
+14.66%
1M
-17.04%
3M
-30.82%
YTD
—
1Y
—
5Y
—
Financial statements
Open full COAG financials →Loading financial statements…
Related Healthcare#
| Ticker | Name | 1M | 1D |
|---|---|---|---|
| LLY | Eli Lilly and Company | +11.34% | +3.49% |
| JNJ | Johnson & Johnson | -3.94% | +2.19% |
| ABBV | AbbVie Inc. | +9.52% | +2.26% |
| UNH | UnitedHealth Group Incorporated Common Stock (DE) | +11.24% | +3.04% |
| MRK | Merck & Co. Inc. | +0.97% | +3.25% |
| NVS | Novartis AG | +9.45% | +2.29% |
| TMO | Thermo Fisher Scientific Inc. | +5.51% | +1.18% |
| AMGN | Amgen Inc. | +13.82% | +3.29% |